Home  >  News
Marketing + Font Resize -

Zydus gets US FDA marketing nod for topiramate ER capsules

Our Bureau, Mumbai
Tuesday, November 28, 2017, 15:15 Hrs  [IST]

Zydus Cadila has received the final approval from the US FDA to market topiramate extended-release capsules in the strengths of 25 mg, 50 mg, and 100 mg. The drug is indicated for the treatment of seizures and migraine headaches. It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 170 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
duphat_150x60
IPJPI18_150x60en_2018
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |